|
1
|
van Meerbeeck JP, Scherpereel A, Surmont
VF and Baas P: Malignant pleural mesothelioma: The standard of care
and challenges for future management. Crit Rev Oncol Hematol.
78:92–111. 2011. View Article : Google Scholar
|
|
2
|
Zucali PA, Ceresoli GL, De Vincenzo F,
Simonelli M, Lorenzi E, Gianoncelli L and Santoro A: Advances in
the biology of malignant pleural mesothelioma. Cancer Treat Rev.
37:543–558. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rascoe PA, Jupiter D, Cao X, Littlejohn JE
and Smythe WR: Molecular pathogenesis of malignant mesothelioma.
Expert Rev Mol Med. 14:e122012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Uematsu K, Kanazawa S, You L, He B, Xu Z,
Li K, Peterlin BM, McCormick F and Jablons DM: Wnt pathway
activation in mesothelioma: Evidence of Dishevelled overexpression
and transcriptional activity of beta-catenin. Cancer Res.
63:4547–4551. 2003.PubMed/NCBI
|
|
5
|
Uematsu K, Seki N, Seto T, Isoe C,
Tsukamoto H, Mikami I, You L, He B, Xu Z, Jablons DM, et al:
Targeting the Wnt signaling pathway with dishevelled and cisplatin
synergistically suppresses mesothelioma cell growth. Anticancer
Res. 27B:4239–4242. 2007.
|
|
6
|
Fox SA, Richards AK, Kusumah I, Perumal V,
Bolitho EM, Mutsaers SE and Dharmarajan AM: Expression profile and
function of Wnt signaling mechanisms in malignant mesothelioma
cells. Biochem Biophys Res Commun. 440:82–87. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Anastas JN and Moon RT: WNT signalling
pathways as therapeutic targets in cancer. Nat Rev Cancer.
13:11–26. 2013. View
Article : Google Scholar
|
|
8
|
Surana R, Sikka S, Cai W, Shin EM, Warrier
SR, Tan HJ, Arfuso F, Fox SA, Dharmarajan AM and Kumar AP: Secreted
frizzled related proteins: Implications in cancers. Biochim Biophys
Acta. 1845:53–65. 2014.
|
|
9
|
Lee AY, He B, You L, Dadfarmay S, Xu Z,
Mazieres J, Mikami I, McCormick F and Jablons DM: Expression of the
secreted frizzled-related protein gene family is downregulated in
human mesothelioma. Oncogene. 23:6672–6676. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He B, Lee AY, Dadfarmay S, You L, Xu Z,
Reguart N, Mazieres J, Mikami I, McCormick F and Jablons DM:
Secreted frizzled-related protein 4 is silenced by hypermethylation
and induces apoptosis in beta-catenin-deficient human mesothelioma
cells. Cancer Res. 65:743–748. 2005.PubMed/NCBI
|
|
11
|
Kohno H, Amatya VJ, Takeshima Y, Kushitani
K, Hattori N, Kohno N and Inai K: Aberrant promoter methylation of
WIF-1 and SFRP1, 2, 4 genes in mesothelioma. Oncol Rep. 24:423–431.
2010.PubMed/NCBI
|
|
12
|
Abutaily AS, Collins JE and Roche WR:
Cadherins, catenins and APC in pleural malignant mesothelioma. J
Pathol. 201:355–362. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Orecchia S, Schillaci F, Salvio M, Libener
R and Betta P-G: Aberrant E-cadherin and gamma-catenin expression
in malignant mesothelioma and its diagnostic and biological
relevance. Lung Cancer. 45(Suppl 1): S37–S43. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin K, Wang S, Julius MA, Kitajewski J,
Moos M Jr and Luyten FP: The cysteine-rich frizzled domain of
Frzb-1 is required and sufficient for modulation of Wnt signaling.
Proc Natl Acad Sci USA. 94:11196–11200. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhat RA, Stauffer B, Komm BS and Bodine
PVN: Structure-function analysis of secreted frizzled-related
protein-1 for its Wnt antagonist function. J Cell Biochem.
102:1519–1528. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lopez-Rios J, Esteve P, Ruiz JM and
Bovolenta P: The Netrin-related domain of Sfrp1 interacts with Wnt
ligands and antagonizes their activity in the anterior neural
plate. Neural Dev. 3:192008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Manning LS, Whitaker D, Murch AR, Garlepp
MJ, Davis MR, Musk AW and Robinson BW: Establishment and
characterization of five human malignant mesothelioma cell lines
derived from pleural effusions. Int J Cancer. 47:285–290. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Whittell LR, Batty KT, Wong RPM, Bolitho
EM, Fox SA, Davis TME and Murray PE: Synthesis and antimalarial
evaluation of novel isocryptolepine derivatives. Bioorg Med Chem.
19:7519–7525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gebäck T, Schulz MMP, Koumoutsakos P and
Detmar M: TScratch: A novel and simple software tool for automated
analysis of monolayer wound healing assays. Biotechniques.
46:265–274. 2009.PubMed/NCBI
|
|
20
|
Cregan IL, Dharmarajan AM and Fox SA:
Mechanisms of cisplatin-induced cell death in malignant
mesothelioma cells: Role of inhibitor of apoptosis proteins (IAPs)
and caspases. Int J Oncol. 42:444–452. 2013.
|
|
21
|
Roth W, Wild-Bode C, Platten M, Grimmel C,
Melkonyan HS, Dichgans J and Weller M: Secreted Frizzled-related
proteins inhibit motility and promote growth of human malignant
glioma cells. Oncogene. 19:4210–4220. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vakifahmetoglu H, Olsson M and Zhivotovsky
B: Death through a tragedy: Mitotic catastrophe. Cell Death Differ.
15:1153–1162. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Horvath LG, Lelliott JE, Kench JG, Lee CS,
Williams ED, Saunders DN, Grygiel JJ, Sutherland RL and Henshall
SM: Secreted frizzled-related protein 4 inhibits proliferation and
metastatic potential in prostate cancer. Prostate. 67:1081–1090.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ford CE, Jary E, Ma SSQ, Nixdorf S,
Heinzelmann-Schwarz VA and Ward RL: The Wnt gatekeeper SFRP4
modulates EMT, cell migration and downstream Wnt signalling in
serous ovarian cancer cells. PLoS One. 8:e543622013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Warrier S, Balu SK, Kumar AP, Millward M
and Dharmarajan A: Wnt antagonist, secreted frizzled-related
protein 4 (sFRP4), increases chemotherapeutic response of glioma
stem-like cells. Oncol Res. 21:93–102. 2013. View Article : Google Scholar
|
|
26
|
Turashvili G, Bouchal J, Burkadze G and
Kolar Z: Wnt signaling pathway in mammary gland development and
carcinogenesis. Pathobiology. 73:213–223. 2006. View Article : Google Scholar
|
|
27
|
Huang D, Yu B, Deng Y, Sheng W, Peng Z,
Qin W and Du X: SFRP4 was overexpressed in colorectal carcinoma. J
Cancer Res Clin Oncol. 136:395–401. 2010. View Article : Google Scholar
|
|
28
|
Mortensen MM, Høyer S, Lynnerup A-S,
Ørntoft TF, Sørensen KD, Borre M and Dyrskjøt L: Expression
profiling of prostate cancer tissue delineates genes associated
with recurrence after prostatectomy. Sci Rep. 5:160182015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lustig B, Jerchow B, Sachs M, Weiler S,
Pietsch T, Karsten U, van de Wetering M, Clevers H, Schlag PM,
Birchmeier W and Behrens J: Negative feedback loop of Wnt signaling
through upregulation of conductin/axin2 in colorectal and liver
tumors. Mol Cell Biol. 22:1184–1193. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Drake JM, Friis RR and Dharmarajan AM: The
role of sFRP4, a secreted frizzled-related protein, in ovulation.
Apoptosis. 8:389–397. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maganga R, Giles N, Adcroft K, Unni A,
Keeney D, Wood F, Fear M and Dharmarajan A: Secreted Frizzled
related protein-4 (sFRP4) promotes epidermal differentiation and
apoptosis. Biochem Biophys Res Commun. 377:606–611. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Muley A, Majumder S, Kolluru GK, Parkinson
S, Viola H, Hool L, Arfuso F, Ganss R, Dharmarajan A and Chatterjee
S: Secreted frizzled-related protein 4: An angiogenesis inhibitor.
Am J Pathol. 176:1505–1516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Carmon KS and Loose DS: Development of a
bioassay for detection of Wnt-binding affinities for individual
frizzled receptors. Anal Biochem. 401:288–294. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rodriguez J, Esteve P, Weinl C, Ruiz JM,
Fermin Y, Trousse F, Dwivedy A, Holt C and Bovolenta P: SFRP1
regulates the growth of retinal ganglion cell axons through the Fz2
receptor. Nat Neurosci. 8:1301–1309. 2005. View Article : Google Scholar : PubMed/NCBI
|
